HQ: Nanaimo, British Columbia
Facilities: Nanaimo, BC. Another opening in Enniskillen, Ontario
Symbol: TLRY (OTC), 2HQF (Franfurt)
Licenses: Cultivation, Production, Sales. Applying for Dealer’s license (for export)
CEO: Brendan Kennedy
Research, cultivation, processing, and distribution of medical cannabis internationally.
Market Cap: $6 billion
Enterprise Value: $4.7 billion
Size (mkt cap) within cannabis industry: 2 of 200+
Size among cultivators: 2 of about 40
# of employees: N/A
Secondary: Germany, the UK, Argentina, Australia, Chile, Croatia, Cyprus, the Czech Republic, New Zealand, South Africa.
Current production: exact figure not available. 100,000 kgs (912,000 sf) by end 2018.
Future production: Max potential is 400,000+ kgs
Direct sales: Yes, it has a large number of current patients
Should you invest in Tilray, Inc. TLRY (NASDAQ)? Recommendation: See Below
Vertically integrated: Yes, cultivation and distribution (not sure how much direct sales)
Horizontally diversified: Not much. Most focus is on cultivation. Some medical R&D,
Revenue rank among cultivators: 5th
Revenue growth (YoY): 97%
Net income per share: N/A
Total cost per gram: $6.38
Cost per gram rank in industry: N/A
CEO: Brendan Kennedy
CFO: Mark Castaneda
CMO: Adine Fabiani-Carter
Chief Revenue Officer: Edward Pastorius
Chief Science Officer: Josh Eades
Head of research: Dr. Catherine Jacobson
The company launched a new cannabis brand called CANACA™, celebrating Canadian roots and pride as the country becomes the world’s first G7 nation to federally legalize cannabis for adult-use.
Tilray signed an agreement with Sandoz Canada, a division of Novartis, to create and sell co-branded and co-developed non-combustible medical cannabis products.
Current share price: $65
Price to Sales: 213 (Tobacco industry = 5)
Price to Book: 137
EV / revenue: 167
EV / revenue rank in the industry: 2nd highest out of the top 20 cultivators (expensive)
The company completed its IPO in July selling 10.3 million shares of Class 2 Common Stock to the public for $17.00 per share. Just a month later, the stock now trades at US$62, a 360% rise. Tilray netted US$163.6 million on the IPO. Proceeds will go to build out cultivation capacity, repay debt, and for future acquisitions and working capital.
Prior to the IPO, it raised US$55 million of Series A funding from institutional investors.
All cannabis stocks present risks due to the relative newness of the company and market. The company is not yet producing real profits, only revenue. It remains to be seen whether Tilray will succeed in the competitive market to emerge as one of the successful cannabis companies in the coming year or two.
Tilray: Featured Cannabis Stock
About Cannin: Your Marijuana Investment Experts
Cannin is your trusted resource for information about marijuana and hemp stock investment opportunities. Our global team of experts evaluates all emerging marijuana and hemp stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana and hemp stock investments for 2020. We provide the latest marijuana investment and hemp investment news and analysis.
Use Cannin as your resource for breaking cannabis and hemp investing news, featured cannabis and hemp company analysis, comprehensive cannabis and hemp stock reports, or get your free trial now and use our Smart Stock Algorithm to take the guesswork out of profiting from the cannabis industry. Is it too late to invest in marijuana or hemp stocks? No! This is the perfect time to invest in Tilray: Featured Cannabis Stock
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana and hemp stocks is now. Are you looking to buy stock in hemp companies or marijuana companies for 2020? Interested in emerging penny hemp stock companies? Looking for the best Canadian marijuana stocks to invest in? We can help.
Predict price movements of marijuana and hemp stocks several hours in advance with our proprietary algorithmic stock trading software.
Profit from the best marijuana stocks – we’ll show you how at cannin.com